Advanced Oncotherapy – Holdings in Company

Advanced Oncotherapy says Mr Alberto Colussi and his company Brahma AG have increased shareholdings in AVO from 238,939,600 shares to 273,062,282 shares with voting right (19.35%).

Health Service Journal – Only together can we beat cancer

Collaboration between public and private organisations is vital if the NHS is to win the war on cancer, says Sanjeev Pandya, CEO of Advanced Oncotherapy (AVO). The government’s latest strategy to improve cancer treatment in the UK is welcome, but extra funding alone is not the answer. Greater collaboration is the key to winning the […]

Advanced Oncotherapy – The Times of India (Kolkata) – Personalized cancer treatment on way

Experts See A Future In Proton Therapy, Feel Research Is Helping Categorize Patients.  Treatment of cancer will gradually move towards personalized medicines, said experts. According to oncologist Peter Hoskin, with the advancement in cancer research, more categories of patients will emerge and treatment will become more personalized.The oncologist was speaking at a convention titled `Controversies […]